Hanna Nylén

Hanna Nylén

UNVERIFIED PROFILE

Are you Hanna Nylén?   Register this Author

Register author
Hanna Nylén

Hanna Nylén

Publications by authors named "Hanna Nylén"

Are you Hanna Nylén?   Register this Author

10Publications

138Reads

8Profile Views

Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.

Medicine (Baltimore) 2016 Aug;95(34):e4631

aDepartment of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden bDepartment of Pharmacology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia cDepartment of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Stockholm, Sweden dDepartment of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400328PMC
August 2016

Effect of Statin Treatment on Plasma 4β-Hydroxycholesterol Concentrations.

Basic Clin Pharmacol Toxicol 2016 Jun 14;118(6):499-502. Epub 2016 Jan 14.

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.12537DOI Listing
June 2016

miRNA-27b levels are associated with CYP3A activity in vitro and in vivo.

Pharmacol Res Perspect 2015 12 27;3(6):e00192. Epub 2015 Oct 27.

Division of Clinical Microbiology Department of Laboratory Medicine Karolinska Institutet Karolinska University Hospital, Huddinge SE-141 86 Stockholm Sweden; Palliative Home Care and Hospice Ward ASIH Stockholm Södra Långbro Park Bergtallsvägen 12SE-125 59 Älvsjö Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prp2.192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777245PMC
December 2015

Quinine compared to 4β-hydroxycholesterol and midazolam as markers for CYP3A induction by rifampicin.

Drug Metab Pharmacokinet 2014 11;29(4):352-5. Epub 2014 Feb 11.

Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2133/dmpk.dmpk-13-sh-138DOI Listing
May 2015

Plasma levels of 25-hydroxyvitamin D3 and in vivo markers of cytochrome P450 3A activity in Swedes and Koreans: effects of a genetic polymorphism and oral contraceptives.

Basic Clin Pharmacol Toxicol 2014 Oct 11;115(4):366-71. Epub 2014 Apr 11.

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcpt.12230DOI Listing
October 2014

Comparison of endogenous 4β-hydroxycholesterol with midazolam as markers for CYP3A4 induction by rifampicin.

Drug Metab Dispos 2013 Aug 14;41(8):1488-93. Epub 2013 May 14.

Division of Clinical Pharmacology C1-68, Karolinska University Hospital, Huddinge, Karolinska Institutet, SE-141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.113.052316DOI Listing
August 2013

Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study.

Drug Metab Dispos 2013 Apr 5;41(4):704-8. Epub 2013 Feb 5.

Karolinska Institutet, Department of Laboratory Medicine, Divisions of Clinical Pharmacology, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dmd.aspetjournals.org/cgi/doi/10.1124/dmd.113.051136
Publisher Site
http://dx.doi.org/10.1124/dmd.113.051136DOI Listing
April 2013

Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.

Eur J Clin Pharmacol 2011 Jul 19;67(7):715-22. Epub 2011 Jan 19.

Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, 141 86, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00228-010-0984-1
Publisher Site
http://dx.doi.org/10.1007/s00228-010-0984-1DOI Listing
July 2011

4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.

Br J Clin Pharmacol 2011 Feb;71(2):183-9

Department of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2125.2010.03773.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040538PMC
February 2011